A significant proportion of stroke patients discontinue secondary prevention medications within 1 year, highlighting the need to target modifiable factors to improve adherence.
Although up to one-third of stroke patients discontinued one or more secondary prevention medications within 1 year of hospital discharge, self-discontinuation of these medications is uncommon. Several potentially modifiable patient, provider, and system-level factors associated with persistence and adherence may be targets for future interventions.
Bushnell et al. (Thu,) studied this question.